|[November 28, 2012]
Obagi Medical Products to Present at The Canaccord Genuity's Medical Technology and Diagnostics Forum Conference
LONG BEACH, Calif. --(Business Wire)--
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical
aesthetic and therapeutic skin health systems, today announced that
President and Chief Executive Officer Albert Hummel will present a
corporate overview at The Canaccord Genuity's Medical Technology and
Diagnostics Forum Conference, at Le Parker Meridien Hotel, New York.
Obagi Medical's presentation will take place at 3:00 p.m. (EST) on
Tuesday, December 4th.
A live webcast of the presentations will be available via the Internet
by visiting the Investor Relations section of the Company's web site at www.obagi.com.
Archived presentations will be available on the web site for 30 days.
About Obagi Medical Products, Inc.
Obagi Medical Products is a specialty pharmaceutical company that
develops, markets and sells, an is a leading provider of, proprietary
topical aesthetic and therapeutic prescription-strength skin care
systems in the physician-dispensed market. Using its Penetrating
Therapeutics™ technologies, Obagi Medical's products are designed to
improve penetration of agents across the skin barrier for common and
visible skin conditions in adult skin including premature aging,
photodamage, hyperpigmentation (irregular or patchy discoloration of the
skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine
lines and wrinkles. Obagi Medical's portfolio, which includes cosmetic,
over-the-counter and prescription products, including 4% hydroquinone,
is sold and promoted only through physician offices and requires
education by a physician on proper use. Obagi's skin care products
include: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C
and hydroquinone system), Obagi® Professional-C (a line of highly stable
vitamin C serums), Obagi Condition &Enhance® for use with cosmetic
procedures to enhance patient outcomes and satisfaction, Obagi
ELASTIderm® Eye Treatments and Obagi CLENZIderm® M.D. acne therapeutic
systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to
dry skin, and Obagi ELASTIderm Décolletage System, Obagi Rosaclear®
System, Obagi ELASTILash® Eyelash Solution, Obagi Blue Peel RADIANCE®,
Nu-Derm® Sun Shield SPF 50 and Nu-Derm® Hydrate. Visit http://www.obagi.com for
Penetrating Therapeutics is a trademark, and Obagi, the Obagi logo, Blue
Peel RADIANCE, Condition & Enhance, ELASTIderm, ELASTILash, Nu-Derm,
Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of
Obagi Medical Products, Inc. and/or its affiliates in the United States
and certain other countries.
[ Back To TMCnet.com's Homepage ]